We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$374M
AUM Growth
+$25.3M
Cap. Flow
+$12.8M
Cap. Flow %
3.42%
Top 10 Hldgs %
52.3%
Holding
780
New
51
Increased
150
Reduced
192
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 9.22%
2 Industrials 3.01%
3 Consumer Discretionary 2.98%
4 Healthcare 2.97%
5 Consumer Staples 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
476
Church & Dwight Co
CHD
$24B
$6.39K ﹤0.01%
61
AIQ icon
477
Global X Artificial Intelligence & Technology ETF
AIQ
$10.3B
$6.33K ﹤0.01%
170
-30
-15% -$1.05K
IGD
478
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$524M
$6.3K ﹤0.01%
1,117
AGCO icon
479
AGCO
AGCO
$7.11B
$6.28K ﹤0.01%
+64
New +$5.96K
EQIX icon
480
Equinix
EQIX
$105B
$6.22K ﹤0.01%
+7
New +$5.73K
KBWD icon
481
Invesco KBW High Dividend Yield Financial ETF
KBWD
$427M
$6.11K ﹤0.01%
400
OEF icon
482
iShares S&P 100 ETF
OEF
$20.4B
$6.09K ﹤0.01%
22
-11
-33% -$2.94K
SOUN icon
483
SoundHound AI
SOUN
$3.29B
$6.06K ﹤0.01%
1,300
+100
+8% +$484
MYGN icon
484
Myriad Genetics
MYGN
$309M
$6.03K ﹤0.01%
220
NEO icon
485
NeoGenomics
NEO
$2.11B
$5.9K ﹤0.01%
400
LULU icon
486
lululemon athletica
LULU
$13.7B
$5.7K ﹤0.01%
21
+20
+2,000% +$5.31K
MINT icon
487
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$5.64K ﹤0.01%
56
-3
-5% -$301
CRON
488
Cronos Group
CRON
$1.17B
$5.63K ﹤0.01%
2,573
ATMU icon
489
Atmus Filtration Technologies
ATMU
$4.06B
$5.63K ﹤0.01%
+150
New +$4.9K
TSHA icon
490
Taysha Gene Therapies
TSHA
$2.05B
$5.63K ﹤0.01%
+2,800
New +$6.14K
ALC icon
491
Alcon
ALC
$35.6B
$5.6K ﹤0.01%
56
UBS icon
492
UBS Group
UBS
$177B
$5.56K ﹤0.01%
180
-416
-70% -$12.5K
DFAR icon
493
Dimensional US Real Estate ETF
DFAR
$1.76B
$5.54K ﹤0.01%
216
+16
+8% +$387
HLN icon
494
Haleon
HLN
$43.2B
$5.53K ﹤0.01%
523
-100
-16% -$967
DOUG icon
495
Douglas Elliman
DOUG
$184M
$5.49K ﹤0.01%
+3,000
New +$5.14K
EL icon
496
Estee Lauder
EL
$31.7B
$5.48K ﹤0.01%
55
TT icon
497
Trane Technologies
TT
$105B
$5.44K ﹤0.01%
14
BMY icon
498
Bristol-Myers Squibb
BMY
$130B
$5.43K ﹤0.01%
105
CRSP icon
499
CRISPR Therapeutics
CRSP
$5.22B
$5.4K ﹤0.01%
115
JQC icon
500
Nuveen Credit Strategies Income Fund
JQC
$717M
$5.4K ﹤0.01%
933

Similar funds

Oliver Lagore Vanvalin Investment Group's Q3 2024 Portfolio in Review

As of Q3 2024, Oliver Lagore Vanvalin Investment Group held 780 positions worth $374M, up 7.3% from $349M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Oliver Lagore Vanvalin Investment Group deployed $12.8M of net new capital in Q3 2024, opening 51 new positions and adding to 150 existing holdings. Its largest new stake was Innovator U.S. Small Cap Power Buffer ETF - September: 77,511 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $25.2M trimmed.

  • Oliver Lagore Vanvalin Investment Group's largest Q3 2024 buy was Innovator U.S. Small Cap Power Buffer ETF - September: 77,511 shares worth $1.98M.
  • Oliver Lagore Vanvalin Investment Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $18.3M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $25.2M.
  • Oliver Lagore Vanvalin Investment Group fully exited Visteon in Q3 2024, selling an estimated $67.8K.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 52% of its $374M portfolio in Q3 2024.
  • Oliver Lagore Vanvalin Investment Group opened 51 new positions and closed 95 in Q3 2024.
  • Oliver Lagore Vanvalin Investment Group's portfolio value rose 7.3% quarter-over-quarter to $374M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2024, filed 4 Nov 2024.